Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Cibenzoline].

P Touboul

    Archives Des Maladies Du Coeur Et Des Vaisseaux
    |October 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Cibenzoline, an antiarrhythmic drug, effectively treats various heart rhythm disorders by influencing cardiac electrical activity and contractility. Clinical studies show its efficacy in preventing atrial and ventricular arrhythmias with rare side effects.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    A decade-long surveillance of nasopharyngeal colonisation with Streptococcus pneumoniae among children attending day-care centres in south-eastern France: 1999-2008.

    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2011
    Same author

    Comparison of primary angioplasty and pre-hospital fibrinolysis in acute myocardial infarction (CAPTIM) trial: a 5-year follow-up.

    European heart journal·2009
    Same author

    [Safety of new anti-arrhythmic drugs].

    Archives des maladies du coeur et des vaisseaux·2005
    Same author

    [New anti-arrhythmics--hope or disappointment?].

    Archives des maladies du coeur et des vaisseaux·2004
    Same author

    [Type of child care and nasopharyngeal S. pneumoniae and H. influenzae carriage in children in the Alpes-Maritimes].

    Presse medicale (Paris, France : 1983)·2004
    Same author

    Microscope in orbit calibration procedure for a test of the equivalence principle at 10(-15).

    Acta astronautica·2003
    Same journal

    Radiokymographic study of the kinetics of the middle arc and the hils in the normal subject.

    Archives des maladies du coeur et des vaisseaux·2010
    Same journal

    A medication for angina pectoris and pre-fibrillatory conditions; 1262 F; six years of clinical experience; action mechanism.

    Archives des maladies du coeur et des vaisseaux·2010
    Same journal

    Circulatory changes following the injection of hypertonic saline solutions; application to the study of angina pectoris.

    Archives des maladies du coeur et des vaisseaux·2010
    Same journal

    Alterations in coronary circulation during aortic insufficiency in young subjects.

    Archives des maladies du coeur et des vaisseaux·2010
    Same journal

    Cardio-esophageal auscultation.

    Archives des maladies du coeur et des vaisseaux·2010
    Same journal

    Hypertensive accidents following the injection of acetylcholine.

    Archives des maladies du coeur et des vaisseaux·2010
    See all related articles

    Area of Science:

    • Pharmacology
    • Cardiology
    • Electrophysiology

    Context:

    • Cibenzoline is an imidazoline derivative with demonstrated antiarrhythmic properties.
    • Understanding its pharmacokinetic and pharmacodynamic profile is crucial for effective clinical application.

    Purpose:

    • To summarize the pharmacokinetic, electrophysiological, and clinical effects of Cibenzoline.
    • To highlight its efficacy in managing diverse cardiac arrhythmias.

    Summary:

    • Cibenzoline exhibits near 100% oral bioavailability and a half-life of 4-7 hours.
    • It depresses left ventricular contraction, increases systemic vascular resistance, and prolongs action potential duration.
    • Electrophysiological studies reveal decreased fast sodium and slow currents, with observed clinical effects including increased QRS duration, AH/HV intervals, and ventricular refractory period.

    Related Experiment Videos

    Impact:

    • Cibenzoline is effective in preventing atrial arrhythmias and treating supraventricular and ventricular tachycardias, including those associated with Wolff-Parkinson-White syndrome.
    • Its favorable side effect profile contributes to its therapeutic utility in managing cardiac arrhythmias.